INFO & CONTACTS:  +39 02 2390 1

Biostatistics for Clinical Research

Milano
Via Augusto Vanzetti, 5, 20133 Milano MI

Dr. Miceli

Dott.ssa Miceli Rosalba

Responsabile

Tipologia: Simple Structure

The mission is to make clinical-biological data informative, by transforming them into information relevant for clinical research and, ultimately, improve the understanding of the oncological disease and outcome of treatments, with the aim of improving patient prognosis. 

This mission is expressed in biostatistical consultancy services with high benefit for observational and experimental clinical studies, in conducting and supporting research projects involving the clinical research area, in promoting the quality and integrity of research and research on gender medicine. This Structure pertains to the Complex Structure Data Science of the Department of Epidemiology and Data Science. 

Main research areas

Biostatistical methodologies for planning and statistical analysis in experimental and observational studies. 

Bioinformatics-statistical techniques for the construction of multiple biomarkers. 

Predictive models of clinical outcomes with the joint use of clinical variables and multiple biomarkers. 

Biostatistical support for the design, statistical analysis, interpretation of results and drafting of manuscripts for experimental and observational clinical studies. 

The Structure catalyzes national and international collaborations and research on specific cancers (sarcoma, melanoma, head and neck, breast, gastrointestinal, liver, CNS, neuroendocrine and urogenital cancers), in both adult and pediatric patients. Examples of statistical methodologies for which particular expertise is available: analysis of survival data (with the application of regression techniques such as mixture models, landmarks, competitive risk models, multistate models), static and dynamic forecasting models, random models forest, meta-analysis techniques. This area also includes the study, maintenance and development of software for carrying out statistical analyses.

Rosalba Miceli, Head of structure

Luisa Emma Morandi (Secretariat)

Dott.ssa Miceli Rosalba
Head

Ricercatori Sanitari Senior  

Barretta Francesco 

Ricercatori Sanitari Junior 

Airoldi Chiara (collaborazione professionale

Iadecola Sara (collaborazione professionale

Ljevar Silva  

Polymeropoulos Alessio 

 

Borsisti  

Garavaglia Alessia 

Perlino Federico 

Tinè Gabriele 

Zhu Yiyi 

 

Personale amministrativo  

Morandi Luisa Emma  

Building Data Rich Clinical Trials (CCE-DART)

Building Data Rich Clinical Trials (CCE-DART)

Artificial intelligence-based analysis of longitudinal breath profiles of head and neck cancer patients’ survivors

Artificial intelligence-based analysis of longitudinal breath profiles of head and neck cancer patients’ survivors

Dissecting immunological effects of neoadjuvant therapies in primary high-risk soft tissue sarcomas

Dissecting immunological effects of neoadjuvant therapies in primary high-risk soft tissue sarcomas

Exploiting Artificial Intelligence-based tools for analysis of clinical breathomics data

Exploiting Artificial Intelligence-based tools for analysis of clinical breathomics data

SENESCENZA COME BIOMARCATORE DELLA FATIGUE CORRELATA AL CANCRO IN PAZIENTI CON CANCRO AL SENO SOTTOPOSTE A CHEMIOTERAPIA ADIUVANTE

SENESCENZA COME BIOMARCATORE DELLA FATIGUE CORRELATA AL CANCRO IN PAZIENTI CON CANCRO AL SENO SOTTOPOSTE A CHEMIOTERAPIA ADIUVANTE

Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach (Late-AYA)

Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach (Late-AYA)

Last update: 10/06/2025

Subscribe to the newsletter

Sign up for our newsletter to stay informed about news, events, and updates from the Institute

Subscribe